PPARG and Hyperglycemia: Our in vitro experimental results demonstrated that rFGF21 is strongly protective in hyperglycemia plus IL-1β -induced transendothelial permeability, which is FGFR1 activation-dependent and PPARγ activity-dependent, and also associated with the maintenance of junction protein expression.